Accord Healthcare, a leading company in generic medicines, has announced the launch of Clomiphene tablets, a generic version of CLOMID® (clomiphene citrate). This new product adds to Accord Healthcare's growing range of medicines for women's health and aims to make safe and affordable treatments more accessible to patients.
Clomiphene citrate is used to help women with ovulatory dysfunction who are trying to get pregnant. By offering this therapy, Accord Healthcare continues its mission to improve healthcare access and support both patients and doctors in managing women's health issues.
- Like any medication, Clomiphene citrate can cause serious side effects, including: Blurred vision or other visual issues like spots or flashes, which may become permanent with higher doses or longer use.
- Ovarian hyperstimulation syndrome (OHSS), a serious condition that can develop quickly.
- More common side effects include enlarged ovaries, hot flashes, pelvic discomfort, nausea, vomiting, and breast tenderness.
Accord Healthcare, part of Intas Pharmaceuticals, is a major company that makes generic drugs. Their goal is to improve people's lives by making medicines more affordable and accessible, while also offering new solutions that make healthcare better for both doctors and patients.
Executive Statement
According to Chrys Kokino, President of Accord Healthcare North America, their primary focus will always be to provide access to high quality, essential medicines for all patients and ensure a positive patient experience. They are pleased to be able to provide Accord Clomiphene tablets as another option for those women who may need this medication. They look forward to continuing to launch and support important products specifically focused on women's healthcare.